nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RXRA—thyroid cancer	0.686	1	CbGaD
Alitretinoin—CRABP1—neck—thyroid cancer	0.00435	0.108	CbGeAlD
Alitretinoin—RXRG—neck—thyroid cancer	0.00344	0.0857	CbGeAlD
Alitretinoin—CRABP1—trachea—thyroid cancer	0.00262	0.0653	CbGeAlD
Alitretinoin—Isotretinoin—RXRA—thyroid cancer	0.0026	0.412	CrCbGaD
Alitretinoin—CRABP2—trachea—thyroid cancer	0.00237	0.059	CbGeAlD
Alitretinoin—Acitretin—RXRA—thyroid cancer	0.00221	0.351	CrCbGaD
Alitretinoin—CRABP1—thyroid gland—thyroid cancer	0.00207	0.0516	CbGeAlD
Alitretinoin—CRABP2—thyroid gland—thyroid cancer	0.00187	0.0467	CbGeAlD
Alitretinoin—CRABP1—head—thyroid cancer	0.00184	0.0458	CbGeAlD
Alitretinoin—RARB—thyroid gland—thyroid cancer	0.00167	0.0418	CbGeAlD
Alitretinoin—CRABP2—head—thyroid cancer	0.00166	0.0414	CbGeAlD
Alitretinoin—RXRA—head—thyroid cancer	0.00165	0.0412	CbGeAlD
Alitretinoin—RXRG—thyroid gland—thyroid cancer	0.00164	0.0408	CbGeAlD
Alitretinoin—RXRB—thyroid gland—thyroid cancer	0.00154	0.0384	CbGeAlD
Alitretinoin—Tretinoin—RXRA—thyroid cancer	0.00149	0.237	CrCbGaD
Alitretinoin—RARB—head—thyroid cancer	0.00149	0.037	CbGeAlD
Alitretinoin—RXRG—head—thyroid cancer	0.00145	0.0362	CbGeAlD
Alitretinoin—RARG—thyroid gland—thyroid cancer	0.00137	0.0341	CbGeAlD
Alitretinoin—RXRB—head—thyroid cancer	0.00137	0.034	CbGeAlD
Alitretinoin—RARA—thyroid gland—thyroid cancer	0.00128	0.032	CbGeAlD
Alitretinoin—RARG—head—thyroid cancer	0.00121	0.0302	CbGeAlD
Alitretinoin—RARA—head—thyroid cancer	0.00114	0.0284	CbGeAlD
Alitretinoin—RARB—lymph node—thyroid cancer	0.00104	0.0259	CbGeAlD
Alitretinoin—RARG—lymph node—thyroid cancer	0.000849	0.0212	CbGeAlD
Alitretinoin—RARA—lymph node—thyroid cancer	0.000798	0.0199	CbGeAlD
Alitretinoin—CYP1A2—thyroid gland—thyroid cancer	0.000476	0.0119	CbGeAlD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000382	0.00312	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000382	0.00312	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00037	0.00303	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000363	0.00297	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000361	0.00295	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.000356	0.00291	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000348	0.00285	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000348	0.00285	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000346	0.00283	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000346	0.00283	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00033	0.0027	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000324	0.00265	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000311	0.00255	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00031	0.00254	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00031	0.00254	CbGpPWpGaD
Alitretinoin—ABCB1—trachea—thyroid cancer	0.000308	0.00769	CbGeAlD
Alitretinoin—RXRG—Adipogenesis—RXRA—thyroid cancer	0.000277	0.00227	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—MINPP1—thyroid cancer	0.000264	0.00216	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—MINPP1—thyroid cancer	0.000264	0.00216	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—RXRA—thyroid cancer	0.000261	0.00213	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000261	0.00213	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000258	0.00211	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000252	0.00206	CbGpPWpGaD
Alitretinoin—RARG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000245	0.002	CbGpPWpGaD
Alitretinoin—ABCB1—thyroid gland—thyroid cancer	0.000244	0.00608	CbGeAlD
Alitretinoin—RXRG—Generic Transcription Pathway—THRB—thyroid cancer	0.000238	0.00195	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—THRB—thyroid cancer	0.000234	0.00191	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—PPARG—thyroid cancer	0.00023	0.00188	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NDUFA13—thyroid cancer	0.000224	0.00184	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NDUFA13—thyroid cancer	0.000224	0.00184	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—THRB—thyroid cancer	0.000224	0.00183	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—THRB—thyroid cancer	0.000224	0.00183	CbGpPWpGaD
Alitretinoin—RXRG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000224	0.00183	CbGpPWpGaD
Alitretinoin—RXRA—PPAR Alpha Pathway—CCND1—thyroid cancer	0.000221	0.00181	CbGpPWpGaD
Alitretinoin—RARB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00022	0.0018	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000219	0.00179	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000219	0.00179	CbGpPWpGaD
Alitretinoin—ABCB1—head—thyroid cancer	0.000216	0.0054	CbGeAlD
Alitretinoin—CRABP1—Metabolism—CHST14—thyroid cancer	0.000211	0.00173	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CHST14—thyroid cancer	0.000211	0.00173	CbGpPWpGaD
Alitretinoin—RARA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00021	0.00172	CbGpPWpGaD
Alitretinoin—RXRB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00021	0.00172	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—HIF1A—thyroid cancer	0.000206	0.00169	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—HIF1A—thyroid cancer	0.000201	0.00164	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.0002	0.00164	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—HIF1A—thyroid cancer	0.000194	0.00159	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000192	0.00157	CbGpPWpGaD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000183	0.0015	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000181	0.00148	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—PPARG—thyroid cancer	0.000175	0.00143	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—TRIM33—thyroid cancer	0.000174	0.00142	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000172	0.00141	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—HPGD—thyroid cancer	0.00017	0.00139	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—HPGD—thyroid cancer	0.00017	0.00139	CbGpPWpGaD
Alitretinoin—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000167	0.00136	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000166	0.00136	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—PPARG—thyroid cancer	0.000165	0.00135	CbGpPWpGaD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000162	0.00132	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000162	0.00132	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—TRIM33—thyroid cancer	0.000159	0.0013	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—TRIM33—thyroid cancer	0.000156	0.00127	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000152	0.00125	CbGpPWpGaD
Alitretinoin—ABCB1—lymph node—thyroid cancer	0.000152	0.00378	CbGeAlD
Alitretinoin—RXRG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000151	0.00124	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—TRIM33—thyroid cancer	0.000149	0.00122	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—TRIM33—thyroid cancer	0.000149	0.00122	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000149	0.00122	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000149	0.00122	CbGpPWpGaD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000148	0.00121	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SLC5A5—thyroid cancer	0.000147	0.00121	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MEN1—thyroid cancer	0.000142	0.00117	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000142	0.00117	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000138	0.00113	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000138	0.00113	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—thyroid cancer	0.000131	0.00107	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—THRB—thyroid cancer	0.000126	0.00103	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000117	0.000961	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—THRB—thyroid cancer	0.000117	0.000956	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000117	0.000954	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000116	0.000945	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—THRB—thyroid cancer	0.000115	0.00094	CbGpPWpGaD
Alitretinoin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000114	0.000782	CcSEcCtD
Alitretinoin—Hypersensitivity—Sorafenib—thyroid cancer	0.000114	0.000782	CcSEcCtD
Alitretinoin—Renal impairment—Doxorubicin—thyroid cancer	0.000113	0.000775	CcSEcCtD
Alitretinoin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000113	0.000772	CcSEcCtD
Alitretinoin—RARB—Gene Expression—THRB—thyroid cancer	0.000113	0.000921	CbGpPWpGaD
Alitretinoin—Face oedema—Epirubicin—thyroid cancer	0.000112	0.00077	CcSEcCtD
Alitretinoin—Asthenia—Sorafenib—thyroid cancer	0.000111	0.000761	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000111	0.000906	CbGpPWpGaD
Alitretinoin—Cardiac arrest—Epirubicin—thyroid cancer	0.000111	0.000758	CcSEcCtD
Alitretinoin—Cardiac failure—Doxorubicin—thyroid cancer	0.00011	0.000756	CcSEcCtD
Alitretinoin—Mood swings—Epirubicin—thyroid cancer	0.00011	0.000756	CcSEcCtD
Alitretinoin—Lethargy—Doxorubicin—thyroid cancer	0.00011	0.000753	CcSEcCtD
Alitretinoin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00011	0.000753	CcSEcCtD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00011	0.000898	CbGpPWpGaD
Alitretinoin—Pruritus—Sorafenib—thyroid cancer	0.00011	0.00075	CcSEcCtD
Alitretinoin—Blood creatinine increased—Epirubicin—thyroid cancer	0.000109	0.000747	CcSEcCtD
Alitretinoin—Dehydration—Epirubicin—thyroid cancer	0.000108	0.000742	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—THRB—thyroid cancer	0.000108	0.000883	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—THRB—thyroid cancer	0.000108	0.000883	CbGpPWpGaD
Alitretinoin—Pain in extremity—Doxorubicin—thyroid cancer	0.000108	0.000738	CcSEcCtD
Alitretinoin—Osteoarthritis—Doxorubicin—thyroid cancer	0.000108	0.000738	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000108	0.000738	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—NRG1—thyroid cancer	0.000107	0.000877	CbGpPWpGaD
Alitretinoin—Dry skin—Epirubicin—thyroid cancer	0.000107	0.000731	CcSEcCtD
Alitretinoin—Affect lability—Doxorubicin—thyroid cancer	0.000106	0.000726	CcSEcCtD
Alitretinoin—Diarrhoea—Sorafenib—thyroid cancer	0.000106	0.000726	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000105	0.000718	CcSEcCtD
Alitretinoin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000104	0.000713	CcSEcCtD
Alitretinoin—Face oedema—Doxorubicin—thyroid cancer	0.000104	0.000712	CcSEcCtD
Alitretinoin—Gastritis—Epirubicin—thyroid cancer	0.000103	0.000706	CcSEcCtD
Alitretinoin—Cardiac arrest—Doxorubicin—thyroid cancer	0.000102	0.000702	CcSEcCtD
Alitretinoin—Dizziness—Sorafenib—thyroid cancer	0.000102	0.000701	CcSEcCtD
Alitretinoin—Mood swings—Doxorubicin—thyroid cancer	0.000102	0.000699	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000101	0.000829	CbGpPWpGaD
Alitretinoin—Abdominal distension—Epirubicin—thyroid cancer	0.000101	0.000694	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—HIF1A—thyroid cancer	0.000101	0.000826	CbGpPWpGaD
Alitretinoin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000101	0.000691	CcSEcCtD
Alitretinoin—Dysphagia—Epirubicin—thyroid cancer	0.000101	0.000689	CcSEcCtD
Alitretinoin—Asthma—Epirubicin—thyroid cancer	0.000101	0.000689	CcSEcCtD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.0001	0.000821	CbGpPWpGaD
Alitretinoin—Dehydration—Doxorubicin—thyroid cancer	0.0001	0.000686	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—RXRA—thyroid cancer	9.94e-05	0.000813	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.94e-05	0.000813	CbGpPWpGaD
Alitretinoin—Dry skin—Doxorubicin—thyroid cancer	9.87e-05	0.000676	CcSEcCtD
Alitretinoin—Pancreatitis—Epirubicin—thyroid cancer	9.86e-05	0.000676	CcSEcCtD
Alitretinoin—Vomiting—Sorafenib—thyroid cancer	9.84e-05	0.000674	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—PPARG—thyroid cancer	9.81e-05	0.000803	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—TPR—thyroid cancer	9.76e-05	0.000799	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TPR—thyroid cancer	9.76e-05	0.000799	CbGpPWpGaD
Alitretinoin—Rash—Sorafenib—thyroid cancer	9.76e-05	0.000669	CcSEcCtD
Alitretinoin—Dermatitis—Sorafenib—thyroid cancer	9.75e-05	0.000668	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	9.7e-05	0.000665	CcSEcCtD
Alitretinoin—Headache—Sorafenib—thyroid cancer	9.7e-05	0.000665	CcSEcCtD
Alitretinoin—Nasopharyngitis—Doxorubicin—thyroid cancer	9.63e-05	0.00066	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PRKAR1A—thyroid cancer	9.6e-05	0.000786	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PRKAR1A—thyroid cancer	9.6e-05	0.000786	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	9.6e-05	0.000786	CbGpPWpGaD
Alitretinoin—Gastritis—Doxorubicin—thyroid cancer	9.53e-05	0.000653	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—RXRA—thyroid cancer	9.53e-05	0.000779	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—RXRA—thyroid cancer	9.53e-05	0.000779	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.53e-05	0.000779	CbGpPWpGaD
Alitretinoin—Dysuria—Epirubicin—thyroid cancer	9.41e-05	0.000645	CcSEcCtD
Alitretinoin—Neutropenia—Epirubicin—thyroid cancer	9.41e-05	0.000645	CcSEcCtD
Alitretinoin—Abdominal distension—Doxorubicin—thyroid cancer	9.37e-05	0.000642	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Epirubicin—thyroid cancer	9.35e-05	0.000641	CcSEcCtD
Alitretinoin—Asthma—Doxorubicin—thyroid cancer	9.31e-05	0.000638	CcSEcCtD
Alitretinoin—Dysphagia—Doxorubicin—thyroid cancer	9.31e-05	0.000638	CcSEcCtD
Alitretinoin—Pollakiuria—Epirubicin—thyroid cancer	9.29e-05	0.000637	CcSEcCtD
Alitretinoin—Nausea—Sorafenib—thyroid cancer	9.2e-05	0.00063	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Epirubicin—thyroid cancer	9.18e-05	0.000629	CcSEcCtD
Alitretinoin—Weight increased—Epirubicin—thyroid cancer	9.16e-05	0.000627	CcSEcCtD
Alitretinoin—Pancreatitis—Doxorubicin—thyroid cancer	9.13e-05	0.000625	CcSEcCtD
Alitretinoin—Weight decreased—Epirubicin—thyroid cancer	9.1e-05	0.000624	CcSEcCtD
Alitretinoin—Pneumonia—Epirubicin—thyroid cancer	9.02e-05	0.000618	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	8.98e-05	0.000735	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.98e-05	0.000735	CbGpPWpGaD
Alitretinoin—Infestation NOS—Epirubicin—thyroid cancer	8.97e-05	0.000615	CcSEcCtD
Alitretinoin—Infestation—Epirubicin—thyroid cancer	8.97e-05	0.000615	CcSEcCtD
Alitretinoin—Drowsiness—Epirubicin—thyroid cancer	8.97e-05	0.000615	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	8.89e-05	0.000609	CcSEcCtD
Alitretinoin—Renal failure—Epirubicin—thyroid cancer	8.82e-05	0.000604	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Epirubicin—thyroid cancer	8.79e-05	0.000603	CcSEcCtD
Alitretinoin—Stomatitis—Epirubicin—thyroid cancer	8.74e-05	0.000599	CcSEcCtD
Alitretinoin—Conjunctivitis—Epirubicin—thyroid cancer	8.72e-05	0.000597	CcSEcCtD
Alitretinoin—Urinary tract infection—Epirubicin—thyroid cancer	8.72e-05	0.000597	CcSEcCtD
Alitretinoin—Dysuria—Doxorubicin—thyroid cancer	8.71e-05	0.000596	CcSEcCtD
Alitretinoin—Neutropenia—Doxorubicin—thyroid cancer	8.71e-05	0.000596	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.7e-05	0.000712	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.7e-05	0.000712	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.66e-05	0.000709	CbGpPWpGaD
Alitretinoin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	8.65e-05	0.000593	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.61e-05	0.000704	CbGpPWpGaD
Alitretinoin—Sweating—Epirubicin—thyroid cancer	8.6e-05	0.000589	CcSEcCtD
Alitretinoin—Pollakiuria—Doxorubicin—thyroid cancer	8.6e-05	0.000589	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—PPARG—thyroid cancer	8.58e-05	0.000702	CbGpPWpGaD
Alitretinoin—Haematuria—Epirubicin—thyroid cancer	8.55e-05	0.000586	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Doxorubicin—thyroid cancer	8.5e-05	0.000582	CcSEcCtD
Alitretinoin—RARG—Gene Expression—TPR—thyroid cancer	8.48e-05	0.000694	CbGpPWpGaD
Alitretinoin—Weight increased—Doxorubicin—thyroid cancer	8.47e-05	0.000581	CcSEcCtD
Alitretinoin—Epistaxis—Epirubicin—thyroid cancer	8.46e-05	0.00058	CcSEcCtD
Alitretinoin—Weight decreased—Doxorubicin—thyroid cancer	8.42e-05	0.000577	CcSEcCtD
Alitretinoin—Sinusitis—Epirubicin—thyroid cancer	8.42e-05	0.000577	CcSEcCtD
Alitretinoin—Agranulocytosis—Epirubicin—thyroid cancer	8.37e-05	0.000574	CcSEcCtD
Alitretinoin—Pneumonia—Doxorubicin—thyroid cancer	8.35e-05	0.000572	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.31e-05	0.00068	CbGpPWpGaD
Alitretinoin—Infestation—Doxorubicin—thyroid cancer	8.3e-05	0.000569	CcSEcCtD
Alitretinoin—Drowsiness—Doxorubicin—thyroid cancer	8.3e-05	0.000569	CcSEcCtD
Alitretinoin—Infestation NOS—Doxorubicin—thyroid cancer	8.3e-05	0.000569	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	8.23e-05	0.000564	CcSEcCtD
Alitretinoin—Renal failure—Doxorubicin—thyroid cancer	8.16e-05	0.000559	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Doxorubicin—thyroid cancer	8.14e-05	0.000557	CcSEcCtD
Alitretinoin—Haemoglobin—Epirubicin—thyroid cancer	8.09e-05	0.000555	CcSEcCtD
Alitretinoin—Stomatitis—Doxorubicin—thyroid cancer	8.09e-05	0.000554	CcSEcCtD
Alitretinoin—Conjunctivitis—Doxorubicin—thyroid cancer	8.07e-05	0.000553	CcSEcCtD
Alitretinoin—Urinary tract infection—Doxorubicin—thyroid cancer	8.07e-05	0.000553	CcSEcCtD
Alitretinoin—Hepatitis—Epirubicin—thyroid cancer	8.05e-05	0.000552	CcSEcCtD
Alitretinoin—Haemorrhage—Epirubicin—thyroid cancer	8.05e-05	0.000552	CcSEcCtD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	8.05e-05	0.000659	CbGpPWpGaD
Alitretinoin—Hypoaesthesia—Epirubicin—thyroid cancer	8.01e-05	0.000549	CcSEcCtD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	8.01e-05	0.000655	CbGpPWpGaD
Alitretinoin—Pharyngitis—Epirubicin—thyroid cancer	7.99e-05	0.000548	CcSEcCtD
Alitretinoin—RXRA—Metabolism—MINPP1—thyroid cancer	7.98e-05	0.000653	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MEN1—thyroid cancer	7.97e-05	0.000652	CbGpPWpGaD
Alitretinoin—Sweating—Doxorubicin—thyroid cancer	7.96e-05	0.000545	CcSEcCtD
Alitretinoin—Urinary tract disorder—Epirubicin—thyroid cancer	7.95e-05	0.000545	CcSEcCtD
Alitretinoin—Oedema peripheral—Epirubicin—thyroid cancer	7.93e-05	0.000544	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	7.93e-05	0.000649	CbGpPWpGaD
Alitretinoin—Haematuria—Doxorubicin—thyroid cancer	7.91e-05	0.000542	CcSEcCtD
Alitretinoin—Urethral disorder—Epirubicin—thyroid cancer	7.89e-05	0.000541	CcSEcCtD
Alitretinoin—Epistaxis—Doxorubicin—thyroid cancer	7.83e-05	0.000536	CcSEcCtD
Alitretinoin—Sinusitis—Doxorubicin—thyroid cancer	7.79e-05	0.000534	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—TRIM33—thyroid cancer	7.78e-05	0.000637	CbGpPWpGaD
Alitretinoin—Visual impairment—Epirubicin—thyroid cancer	7.76e-05	0.000532	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—TPR—thyroid cancer	7.76e-05	0.000635	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Doxorubicin—thyroid cancer	7.75e-05	0.000531	CcSEcCtD
Alitretinoin—Erythema multiforme—Epirubicin—thyroid cancer	7.61e-05	0.000522	CcSEcCtD
Alitretinoin—RARB—Gene Expression—TPR—thyroid cancer	7.61e-05	0.000622	CbGpPWpGaD
Alitretinoin—Eye disorder—Epirubicin—thyroid cancer	7.53e-05	0.000516	CcSEcCtD
Alitretinoin—Tinnitus—Epirubicin—thyroid cancer	7.51e-05	0.000514	CcSEcCtD
Alitretinoin—Haemoglobin—Doxorubicin—thyroid cancer	7.49e-05	0.000513	CcSEcCtD
Alitretinoin—Flushing—Epirubicin—thyroid cancer	7.47e-05	0.000512	CcSEcCtD
Alitretinoin—Haemorrhage—Doxorubicin—thyroid cancer	7.45e-05	0.000511	CcSEcCtD
Alitretinoin—Hepatitis—Doxorubicin—thyroid cancer	7.45e-05	0.000511	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—MEN1—thyroid cancer	7.42e-05	0.000607	CbGpPWpGaD
Alitretinoin—Hypoaesthesia—Doxorubicin—thyroid cancer	7.41e-05	0.000508	CcSEcCtD
Alitretinoin—Pharyngitis—Doxorubicin—thyroid cancer	7.4e-05	0.000507	CcSEcCtD
Alitretinoin—Urinary tract disorder—Doxorubicin—thyroid cancer	7.36e-05	0.000504	CcSEcCtD
Alitretinoin—Oedema peripheral—Doxorubicin—thyroid cancer	7.34e-05	0.000503	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—SLC5A5—thyroid cancer	7.31e-05	0.000598	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SLC5A5—thyroid cancer	7.31e-05	0.000598	CbGpPWpGaD
Alitretinoin—Angiopathy—Epirubicin—thyroid cancer	7.31e-05	0.000501	CcSEcCtD
Alitretinoin—Urethral disorder—Doxorubicin—thyroid cancer	7.3e-05	0.0005	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—MEN1—thyroid cancer	7.29e-05	0.000597	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—TPR—thyroid cancer	7.29e-05	0.000597	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—TPR—thyroid cancer	7.29e-05	0.000597	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	7.26e-05	0.000594	CbGpPWpGaD
Alitretinoin—Chills—Epirubicin—thyroid cancer	7.23e-05	0.000495	CcSEcCtD
Alitretinoin—Arrhythmia—Epirubicin—thyroid cancer	7.19e-05	0.000493	CcSEcCtD
Alitretinoin—Visual impairment—Doxorubicin—thyroid cancer	7.18e-05	0.000492	CcSEcCtD
Alitretinoin—RARB—Gene Expression—MEN1—thyroid cancer	7.15e-05	0.000585	CbGpPWpGaD
Alitretinoin—Alopecia—Epirubicin—thyroid cancer	7.12e-05	0.000488	CcSEcCtD
Alitretinoin—Mental disorder—Epirubicin—thyroid cancer	7.06e-05	0.000483	CcSEcCtD
Alitretinoin—Erythema multiforme—Doxorubicin—thyroid cancer	7.05e-05	0.000483	CcSEcCtD
Alitretinoin—Erythema—Epirubicin—thyroid cancer	7.01e-05	0.00048	CcSEcCtD
Alitretinoin—Malnutrition—Epirubicin—thyroid cancer	7.01e-05	0.00048	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—PPARG—thyroid cancer	6.99e-05	0.000572	CbGpPWpGaD
Alitretinoin—Eye disorder—Doxorubicin—thyroid cancer	6.96e-05	0.000477	CcSEcCtD
Alitretinoin—Tinnitus—Doxorubicin—thyroid cancer	6.95e-05	0.000476	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	6.94e-05	0.000568	CbGpPWpGaD
Alitretinoin—Flushing—Doxorubicin—thyroid cancer	6.92e-05	0.000474	CcSEcCtD
Alitretinoin—Flatulence—Epirubicin—thyroid cancer	6.91e-05	0.000473	CcSEcCtD
Alitretinoin—Tension—Epirubicin—thyroid cancer	6.88e-05	0.000471	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—MEN1—thyroid cancer	6.86e-05	0.000561	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MEN1—thyroid cancer	6.86e-05	0.000561	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.85e-05	0.00056	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.85e-05	0.00056	CbGpPWpGaD
Alitretinoin—Nervousness—Epirubicin—thyroid cancer	6.81e-05	0.000467	CcSEcCtD
Alitretinoin—RXRA—Metabolism—NDUFA13—thyroid cancer	6.79e-05	0.000556	CbGpPWpGaD
Alitretinoin—Back pain—Epirubicin—thyroid cancer	6.78e-05	0.000465	CcSEcCtD
Alitretinoin—Angiopathy—Doxorubicin—thyroid cancer	6.76e-05	0.000463	CcSEcCtD
Alitretinoin—Chills—Doxorubicin—thyroid cancer	6.69e-05	0.000458	CcSEcCtD
Alitretinoin—Arrhythmia—Doxorubicin—thyroid cancer	6.66e-05	0.000456	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.65e-05	0.000544	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	6.62e-05	0.000541	CbGpPWpGaD
Alitretinoin—Vision blurred—Epirubicin—thyroid cancer	6.61e-05	0.000453	CcSEcCtD
Alitretinoin—Alopecia—Doxorubicin—thyroid cancer	6.58e-05	0.000451	CcSEcCtD
Alitretinoin—Mental disorder—Doxorubicin—thyroid cancer	6.53e-05	0.000447	CcSEcCtD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	6.53e-05	0.000534	CbGpPWpGaD
Alitretinoin—Ill-defined disorder—Epirubicin—thyroid cancer	6.5e-05	0.000446	CcSEcCtD
Alitretinoin—Malnutrition—Doxorubicin—thyroid cancer	6.49e-05	0.000444	CcSEcCtD
Alitretinoin—Erythema—Doxorubicin—thyroid cancer	6.49e-05	0.000444	CcSEcCtD
Alitretinoin—Anaemia—Epirubicin—thyroid cancer	6.48e-05	0.000444	CcSEcCtD
Alitretinoin—Agitation—Epirubicin—thyroid cancer	6.44e-05	0.000441	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—PPARG—thyroid cancer	6.4e-05	0.000523	CbGpPWpGaD
Alitretinoin—Flatulence—Doxorubicin—thyroid cancer	6.39e-05	0.000438	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CHST14—thyroid cancer	6.38e-05	0.000522	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.38e-05	0.000522	CbGpPWpGaD
Alitretinoin—Tension—Doxorubicin—thyroid cancer	6.37e-05	0.000436	CcSEcCtD
Alitretinoin—Malaise—Epirubicin—thyroid cancer	6.32e-05	0.000433	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—TPR—thyroid cancer	6.31e-05	0.000516	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—CP—thyroid cancer	6.31e-05	0.000516	CbGpPWpGaD
Alitretinoin—Nervousness—Doxorubicin—thyroid cancer	6.3e-05	0.000432	CcSEcCtD
Alitretinoin—Syncope—Epirubicin—thyroid cancer	6.29e-05	0.000431	CcSEcCtD
Alitretinoin—Back pain—Doxorubicin—thyroid cancer	6.27e-05	0.00043	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—PPARG—thyroid cancer	6.27e-05	0.000513	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.21e-05	0.000508	CbGpPWpGaD
Alitretinoin—Palpitations—Epirubicin—thyroid cancer	6.2e-05	0.000424	CcSEcCtD
Alitretinoin—Loss of consciousness—Epirubicin—thyroid cancer	6.16e-05	0.000422	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—RXRA—thyroid cancer	6.14e-05	0.000502	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—RXRA—thyroid cancer	6.14e-05	0.000502	CbGpPWpGaD
Alitretinoin—Cough—Epirubicin—thyroid cancer	6.12e-05	0.000419	CcSEcCtD
Alitretinoin—Vision blurred—Doxorubicin—thyroid cancer	6.11e-05	0.000419	CcSEcCtD
Alitretinoin—Convulsion—Epirubicin—thyroid cancer	6.07e-05	0.000416	CcSEcCtD
Alitretinoin—Hypertension—Epirubicin—thyroid cancer	6.05e-05	0.000415	CcSEcCtD
Alitretinoin—Ill-defined disorder—Doxorubicin—thyroid cancer	6.02e-05	0.000412	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARG—thyroid cancer	6.01e-05	0.000492	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PPARG—thyroid cancer	6.01e-05	0.000492	CbGpPWpGaD
Alitretinoin—Anaemia—Doxorubicin—thyroid cancer	6e-05	0.000411	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.97e-05	0.000489	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.97e-05	0.000489	CbGpPWpGaD
Alitretinoin—Chest pain—Epirubicin—thyroid cancer	5.97e-05	0.000409	CcSEcCtD
Alitretinoin—Myalgia—Epirubicin—thyroid cancer	5.97e-05	0.000409	CcSEcCtD
Alitretinoin—Arthralgia—Epirubicin—thyroid cancer	5.97e-05	0.000409	CcSEcCtD
Alitretinoin—Agitation—Doxorubicin—thyroid cancer	5.96e-05	0.000408	CcSEcCtD
Alitretinoin—Anxiety—Epirubicin—thyroid cancer	5.95e-05	0.000408	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	5.93e-05	0.000406	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.91e-05	0.000484	CbGpPWpGaD
Alitretinoin—Discomfort—Epirubicin—thyroid cancer	5.9e-05	0.000404	CcSEcCtD
Alitretinoin—Malaise—Doxorubicin—thyroid cancer	5.85e-05	0.000401	CcSEcCtD
Alitretinoin—Dry mouth—Epirubicin—thyroid cancer	5.84e-05	0.0004	CcSEcCtD
Alitretinoin—Syncope—Doxorubicin—thyroid cancer	5.82e-05	0.000399	CcSEcCtD
Alitretinoin—Confusional state—Epirubicin—thyroid cancer	5.77e-05	0.000395	CcSEcCtD
Alitretinoin—Palpitations—Doxorubicin—thyroid cancer	5.73e-05	0.000393	CcSEcCtD
Alitretinoin—Anaphylactic shock—Epirubicin—thyroid cancer	5.72e-05	0.000392	CcSEcCtD
Alitretinoin—Oedema—Epirubicin—thyroid cancer	5.72e-05	0.000392	CcSEcCtD
Alitretinoin—Loss of consciousness—Doxorubicin—thyroid cancer	5.7e-05	0.000391	CcSEcCtD
Alitretinoin—Infection—Epirubicin—thyroid cancer	5.68e-05	0.000389	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.67e-05	0.000464	CbGpPWpGaD
Alitretinoin—Cough—Doxorubicin—thyroid cancer	5.66e-05	0.000388	CcSEcCtD
Alitretinoin—Shock—Epirubicin—thyroid cancer	5.63e-05	0.000386	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—THRB—thyroid cancer	5.63e-05	0.00046	CbGpPWpGaD
Alitretinoin—Convulsion—Doxorubicin—thyroid cancer	5.62e-05	0.000385	CcSEcCtD
Alitretinoin—Nervous system disorder—Epirubicin—thyroid cancer	5.61e-05	0.000384	CcSEcCtD
Alitretinoin—Thrombocytopenia—Epirubicin—thyroid cancer	5.6e-05	0.000384	CcSEcCtD
Alitretinoin—Hypertension—Doxorubicin—thyroid cancer	5.6e-05	0.000384	CcSEcCtD
Alitretinoin—Tachycardia—Epirubicin—thyroid cancer	5.58e-05	0.000383	CcSEcCtD
Alitretinoin—Skin disorder—Epirubicin—thyroid cancer	5.56e-05	0.000381	CcSEcCtD
Alitretinoin—Hyperhidrosis—Epirubicin—thyroid cancer	5.53e-05	0.000379	CcSEcCtD
Alitretinoin—Chest pain—Doxorubicin—thyroid cancer	5.52e-05	0.000378	CcSEcCtD
Alitretinoin—Myalgia—Doxorubicin—thyroid cancer	5.52e-05	0.000378	CcSEcCtD
Alitretinoin—Arthralgia—Doxorubicin—thyroid cancer	5.52e-05	0.000378	CcSEcCtD
Alitretinoin—Anxiety—Doxorubicin—thyroid cancer	5.5e-05	0.000377	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	5.48e-05	0.000376	CcSEcCtD
Alitretinoin—Discomfort—Doxorubicin—thyroid cancer	5.46e-05	0.000374	CcSEcCtD
Alitretinoin—Anorexia—Epirubicin—thyroid cancer	5.45e-05	0.000374	CcSEcCtD
Alitretinoin—Dry mouth—Doxorubicin—thyroid cancer	5.4e-05	0.00037	CcSEcCtD
Alitretinoin—Hypotension—Epirubicin—thyroid cancer	5.35e-05	0.000366	CcSEcCtD
Alitretinoin—Confusional state—Doxorubicin—thyroid cancer	5.34e-05	0.000366	CcSEcCtD
Alitretinoin—RARG—Gene Expression—RXRA—thyroid cancer	5.33e-05	0.000436	CbGpPWpGaD
Alitretinoin—Oedema—Doxorubicin—thyroid cancer	5.29e-05	0.000363	CcSEcCtD
Alitretinoin—Anaphylactic shock—Doxorubicin—thyroid cancer	5.29e-05	0.000363	CcSEcCtD
Alitretinoin—Infection—Doxorubicin—thyroid cancer	5.26e-05	0.00036	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	5.21e-05	0.000357	CcSEcCtD
Alitretinoin—Shock—Doxorubicin—thyroid cancer	5.21e-05	0.000357	CcSEcCtD
Alitretinoin—Nervous system disorder—Doxorubicin—thyroid cancer	5.19e-05	0.000356	CcSEcCtD
Alitretinoin—Thrombocytopenia—Doxorubicin—thyroid cancer	5.18e-05	0.000355	CcSEcCtD
Alitretinoin—Insomnia—Epirubicin—thyroid cancer	5.18e-05	0.000355	CcSEcCtD
Alitretinoin—Tachycardia—Doxorubicin—thyroid cancer	5.17e-05	0.000354	CcSEcCtD
Alitretinoin—RXRA—Metabolism—HPGD—thyroid cancer	5.15e-05	0.000421	CbGpPWpGaD
Alitretinoin—Skin disorder—Doxorubicin—thyroid cancer	5.14e-05	0.000352	CcSEcCtD
Alitretinoin—Paraesthesia—Epirubicin—thyroid cancer	5.14e-05	0.000352	CcSEcCtD
Alitretinoin—Hyperhidrosis—Doxorubicin—thyroid cancer	5.12e-05	0.000351	CcSEcCtD
Alitretinoin—Dyspnoea—Epirubicin—thyroid cancer	5.1e-05	0.00035	CcSEcCtD
Alitretinoin—Somnolence—Epirubicin—thyroid cancer	5.09e-05	0.000349	CcSEcCtD
Alitretinoin—Anorexia—Doxorubicin—thyroid cancer	5.05e-05	0.000346	CcSEcCtD
Alitretinoin—Dyspepsia—Epirubicin—thyroid cancer	5.04e-05	0.000345	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—CDK1—thyroid cancer	5.03e-05	0.000412	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.99e-05	0.000409	CbGpPWpGaD
Alitretinoin—Decreased appetite—Epirubicin—thyroid cancer	4.97e-05	0.000341	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.96e-05	0.000406	CbGpPWpGaD
Alitretinoin—Hypotension—Doxorubicin—thyroid cancer	4.95e-05	0.000339	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	4.95e-05	0.000405	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Epirubicin—thyroid cancer	4.94e-05	0.000338	CcSEcCtD
Alitretinoin—Fatigue—Epirubicin—thyroid cancer	4.93e-05	0.000338	CcSEcCtD
Alitretinoin—Pain—Epirubicin—thyroid cancer	4.89e-05	0.000335	CcSEcCtD
Alitretinoin—Constipation—Epirubicin—thyroid cancer	4.89e-05	0.000335	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—RXRA—thyroid cancer	4.88e-05	0.000399	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	4.82e-05	0.00033	CcSEcCtD
Alitretinoin—Insomnia—Doxorubicin—thyroid cancer	4.79e-05	0.000328	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.79e-05	0.000392	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—RXRA—thyroid cancer	4.78e-05	0.000391	CbGpPWpGaD
Alitretinoin—Paraesthesia—Doxorubicin—thyroid cancer	4.75e-05	0.000326	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.72e-05	0.000386	CbGpPWpGaD
Alitretinoin—Dyspnoea—Doxorubicin—thyroid cancer	4.72e-05	0.000323	CcSEcCtD
Alitretinoin—Feeling abnormal—Epirubicin—thyroid cancer	4.72e-05	0.000323	CcSEcCtD
Alitretinoin—Somnolence—Doxorubicin—thyroid cancer	4.71e-05	0.000322	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Epirubicin—thyroid cancer	4.68e-05	0.000321	CcSEcCtD
Alitretinoin—Dyspepsia—Doxorubicin—thyroid cancer	4.66e-05	0.000319	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.63e-05	0.000379	CbGpPWpGaD
Alitretinoin—Decreased appetite—Doxorubicin—thyroid cancer	4.6e-05	0.000315	CcSEcCtD
Alitretinoin—RARA—Gene Expression—RXRA—thyroid cancer	4.59e-05	0.000375	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—RXRA—thyroid cancer	4.59e-05	0.000375	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	4.57e-05	0.000313	CcSEcCtD
Alitretinoin—Fatigue—Doxorubicin—thyroid cancer	4.56e-05	0.000313	CcSEcCtD
Alitretinoin—Urticaria—Epirubicin—thyroid cancer	4.55e-05	0.000311	CcSEcCtD
Alitretinoin—Pain—Doxorubicin—thyroid cancer	4.53e-05	0.00031	CcSEcCtD
Alitretinoin—Constipation—Doxorubicin—thyroid cancer	4.53e-05	0.00031	CcSEcCtD
Alitretinoin—Body temperature increased—Epirubicin—thyroid cancer	4.52e-05	0.00031	CcSEcCtD
Alitretinoin—Abdominal pain—Epirubicin—thyroid cancer	4.52e-05	0.00031	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.49e-05	0.000367	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Doxorubicin—thyroid cancer	4.36e-05	0.000299	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.33e-05	0.000354	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Doxorubicin—thyroid cancer	4.33e-05	0.000297	CcSEcCtD
Alitretinoin—Hypersensitivity—Epirubicin—thyroid cancer	4.22e-05	0.000289	CcSEcCtD
Alitretinoin—Urticaria—Doxorubicin—thyroid cancer	4.21e-05	0.000288	CcSEcCtD
Alitretinoin—Abdominal pain—Doxorubicin—thyroid cancer	4.19e-05	0.000287	CcSEcCtD
Alitretinoin—Body temperature increased—Doxorubicin—thyroid cancer	4.19e-05	0.000287	CcSEcCtD
Alitretinoin—Asthenia—Epirubicin—thyroid cancer	4.11e-05	0.000281	CcSEcCtD
Alitretinoin—Pruritus—Epirubicin—thyroid cancer	4.05e-05	0.000277	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.99e-05	0.000327	CbGpPWpGaD
Alitretinoin—Diarrhoea—Epirubicin—thyroid cancer	3.91e-05	0.000268	CcSEcCtD
Alitretinoin—Hypersensitivity—Doxorubicin—thyroid cancer	3.9e-05	0.000267	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PPARG—thyroid cancer	3.88e-05	0.000317	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARG—thyroid cancer	3.88e-05	0.000317	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	3.85e-05	0.000315	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—TPR—thyroid cancer	3.8e-05	0.000311	CbGpPWpGaD
Alitretinoin—Asthenia—Doxorubicin—thyroid cancer	3.8e-05	0.00026	CcSEcCtD
Alitretinoin—Dizziness—Epirubicin—thyroid cancer	3.78e-05	0.000259	CcSEcCtD
Alitretinoin—Pruritus—Doxorubicin—thyroid cancer	3.75e-05	0.000257	CcSEcCtD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.69e-05	0.000302	CbGpPWpGaD
Alitretinoin—Vomiting—Epirubicin—thyroid cancer	3.64e-05	0.000249	CcSEcCtD
Alitretinoin—Diarrhoea—Doxorubicin—thyroid cancer	3.62e-05	0.000248	CcSEcCtD
Alitretinoin—Rash—Epirubicin—thyroid cancer	3.61e-05	0.000247	CcSEcCtD
Alitretinoin—Dermatitis—Epirubicin—thyroid cancer	3.6e-05	0.000247	CcSEcCtD
Alitretinoin—Headache—Epirubicin—thyroid cancer	3.58e-05	0.000246	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—MEN1—thyroid cancer	3.57e-05	0.000292	CbGpPWpGaD
Alitretinoin—Dizziness—Doxorubicin—thyroid cancer	3.5e-05	0.00024	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—RXRA—thyroid cancer	3.47e-05	0.000284	CbGpPWpGaD
Alitretinoin—Nausea—Epirubicin—thyroid cancer	3.4e-05	0.000233	CcSEcCtD
Alitretinoin—RARG—Gene Expression—PPARG—thyroid cancer	3.37e-05	0.000276	CbGpPWpGaD
Alitretinoin—Vomiting—Doxorubicin—thyroid cancer	3.37e-05	0.000231	CcSEcCtD
Alitretinoin—Rash—Doxorubicin—thyroid cancer	3.34e-05	0.000229	CcSEcCtD
Alitretinoin—Dermatitis—Doxorubicin—thyroid cancer	3.34e-05	0.000228	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.32e-05	0.000272	CbGpPWpGaD
Alitretinoin—Headache—Doxorubicin—thyroid cancer	3.32e-05	0.000227	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	3.31e-05	0.000271	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MINPP1—thyroid cancer	3.19e-05	0.000261	CbGpPWpGaD
Alitretinoin—Nausea—Doxorubicin—thyroid cancer	3.14e-05	0.000215	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—thyroid cancer	3.13e-05	0.000256	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—thyroid cancer	3.08e-05	0.000252	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—thyroid cancer	3.05e-05	0.00025	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—thyroid cancer	3.05e-05	0.00025	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—thyroid cancer	3.02e-05	0.000247	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TPR—thyroid cancer	2.96e-05	0.000242	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.95e-05	0.000242	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—thyroid cancer	2.95e-05	0.000241	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PRKAR1A—thyroid cancer	2.91e-05	0.000238	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—thyroid cancer	2.9e-05	0.000237	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—thyroid cancer	2.9e-05	0.000237	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	2.82e-05	0.00023	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.71e-05	0.000222	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTEN—thyroid cancer	2.66e-05	0.000218	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—thyroid cancer	2.66e-05	0.000218	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.64e-05	0.000216	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CHST14—thyroid cancer	2.55e-05	0.000209	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.55e-05	0.000208	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.52e-05	0.000206	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.52e-05	0.000206	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.5e-05	0.000204	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.48e-05	0.000203	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.33e-05	0.000191	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC5A5—thyroid cancer	2.21e-05	0.000181	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.17e-05	0.000177	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.07e-05	0.00017	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HPGD—thyroid cancer	2.06e-05	0.000168	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CHST14—thyroid cancer	2.04e-05	0.000167	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.98e-05	0.000162	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.89e-05	0.000154	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.81e-05	0.000148	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NRAS—thyroid cancer	1.81e-05	0.000148	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.79e-05	0.000147	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.73e-05	0.000142	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HPGD—thyroid cancer	1.64e-05	0.000134	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.59e-05	0.00013	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—thyroid cancer	1.55e-05	0.000127	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—thyroid cancer	1.53e-05	0.000125	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—thyroid cancer	1.53e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—thyroid cancer	1.51e-05	0.000123	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.33e-05	0.000109	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—thyroid cancer	1.33e-05	0.000109	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.33e-05	0.000109	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—thyroid cancer	1.32e-05	0.000108	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—thyroid cancer	1.22e-05	9.96e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—thyroid cancer	1.19e-05	9.77e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TPR—thyroid cancer	1.18e-05	9.66e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.18e-05	9.66e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—thyroid cancer	1.17e-05	9.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—thyroid cancer	1.17e-05	9.55e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.16e-05	9.51e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—thyroid cancer	1.14e-05	9.37e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—thyroid cancer	1.14e-05	9.37e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.97e-06	8.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TPR—thyroid cancer	9.43e-06	7.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	9.28e-06	7.59e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—thyroid cancer	9.23e-06	7.55e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A5—thyroid cancer	8.84e-06	7.23e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.41e-06	6.88e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—thyroid cancer	8.05e-06	6.59e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RXRA—thyroid cancer	7.43e-06	6.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	7.06e-06	5.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.61e-06	5.41e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—thyroid cancer	5.97e-06	4.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RXRA—thyroid cancer	5.93e-06	4.85e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.77e-06	4.72e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—thyroid cancer	4.69e-06	3.84e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—thyroid cancer	4.64e-06	3.8e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—thyroid cancer	3.74e-06	3.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—thyroid cancer	3.69e-06	3.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—thyroid cancer	3.22e-06	2.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.95e-06	2.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—thyroid cancer	2.57e-06	2.1e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—thyroid cancer	1.85e-06	1.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—thyroid cancer	1.48e-06	1.21e-05	CbGpPWpGaD
